Mechanisms underlying the synaptic trafficking of the glutamate delta receptor GluD1

2019 ◽  
Vol 24 (10) ◽  
pp. 1451-1460 ◽  
Author(s):  
Wucheng Tao ◽  
Chenxue Ma ◽  
Michael A. Bemben ◽  
Kathy H. Li ◽  
Alma L. Burlingame ◽  
...  
Keyword(s):  
1989 ◽  
Author(s):  
Joe L. Martinez ◽  
Gery Schulteis ◽  
Brian E. Derrick ◽  
Susan B. Weinberger

1985 ◽  
Vol 59 (3) ◽  
pp. 959-968 ◽  
Author(s):  
J. I. Schaeffer ◽  
G. G. Haddad

To study the effect of endorphins on metabolic rate and on the relationship between O2 consumption (VO2) and ventilation, we administered enkephalin analogues (relatively selective delta-receptor agonists) and a morphiceptin analogue (a highly selective mu-receptor agonist) intracisternally in nine unanesthetized chronically instrumented adult dogs. Both delta- and mu-agonists decreased VO2 by 40–60%. delta-Agonists induced a dose-dependent decrease in mean instantaneous minute ventilation (VT/TT) associated with periodic breathing. The decrease in VT/TT started and resolved prior to the decrease and returned to baseline of VO2, respectively. In contrast, the mu-agonists induced an increase in VT/TT associated with rapid shallow breathing. Arterial PCO2 increased and arterial PO2 decreased after both delta- and mu-agonists. Low doses of intracisternal naloxone (0.002–2.0 micrograms/kg) reversed the opioid effect on VT/TT but not on VO2; higher doses of naloxone (5–25 micrograms/kg) reversed both. Naloxone administered alone had no effect on VT/TT or VO2. These data suggest that 1) both delta- and mu-agonists induce alveolar hypoventilation despite a decrease in VO2, 2) this hypoventilation results from a decrease in VT/TT after delta-agonists but an increase in dead space ventilation after mu-agonists, and 3) endorphins do not modulate ventilation and metabolic rate tonically, but we speculate that they may do so in response to stressful stimulation.


2013 ◽  
Vol 113 (suppl_1) ◽  
Author(s):  
Juliana P Borges ◽  
Marina Tristao ◽  
Eduardo V Tibiriçá ◽  
Marcos A Lessa

Introduction: Recent studies showed that exercise enhances myocardial tolerance to ischemia-reperfusion (I-R) injury via an opioid receptor-dependent mechanism. However, the specific subtype of opioid receptor involved in this response remains to be determined. Methods: Male Wistar rats were first divided into 2 groups: exercised and control. The exercised group underwent 4 consecutive days of treadmill training (60 min at 70% of maximal oxygen consumption). The exercised group was then divided into 4 subgroups: exercised (Exe; n = 10); exercised + kappa receptor antagonist (Exe + K; n=4); exercised + delta receptor antagonist (Exe + D; n=4); exercised + mu receptor antagonist (Exe + M; n=4). Control group was also divided into 2 groups: control (Ctr; n = 10) and control sham (Sham; n = 10). To induce I-R injury, anesthetized animals were submitted to a left thoracotomy and a 30 min interventricular coronary occlusion followed by 60 min of reperfusion. The hemodynamic parameters were recorded and infarct size was post-mortem determined by double staining using TTC/Evans blue and expressed as a percentage of the area at risk. Results: As shown in the figure, Sham group showed no infarct, Exe group showed a significant reduction in the infarcted area (27.6%) when compared to Ctr group (42.0%). The pretreatment with mu and kappa receptor antagonist did not alter the cardioprotective effect of exercise. However, the pretreatment with delta receptor antagonist prevented the exercise-induced cardioprotection. Conclusions: Endogenous opioid system is involved in cardioprotection conferred by acute exercise, and delta receptor subtype seems to play an important role in this response.


1984 ◽  
Vol 246 (4) ◽  
pp. G386-G392
Author(s):  
R. Fogel ◽  
R. B. Kaplan

Intraluminal administration of naloxone (10(-4) M), a mu-opiate receptor antagonist, or diprenorphine (10(-6) M), an opiate receptor antagonist with high affinity for both delta- and mu-receptors, decreased basal in vivo water and electrolyte absorption in the jejunum and ileum but not the colon of the rat. Diprenorphine (10(-5) M) decreased basal colonic water transport. These changes were not due to a reduction in mucosal Na-K-ATPase activity. Intravenous atropine prevented as well as abolished the changes in water transport due to naloxone. The diprenorphine-induced changes were not altered by atropine. Naloxone and diprenorphine acted by different receptors. Pretreatment with naloxone (10(-4) M) prevented the increase in water transport due to morphine, a mu-agonist, whereas a higher concentration of naloxone (10(-3) M) was required to inhibit the increase due to D-Ala-methionine-enkephalinamide, a delta-receptor agonist. In contrast, diprenorphine (10(-6) M) abolished the absorption caused by morphine and D-Ala-methionine-enkephalinamide. Diprenorphine (3 X 10(-7) M) partially prevented the morphine-induced increase in water absorption.(ABSTRACT TRUNCATED AT 250 WORDS)


1987 ◽  
Vol 35 (1) ◽  
pp. 256-261
Author(s):  
KUNIO OKUMURA ◽  
YASUMARU HATANAKA ◽  
HITOSHI NAKAYAMA ◽  
YUICHI KANAOKA

Peptides ◽  
1992 ◽  
Vol 13 (4) ◽  
pp. 691-694 ◽  
Author(s):  
Richard B. Rothman ◽  
Victor Bykov ◽  
Arthur E. Jacobson ◽  
Kenner C. Rice ◽  
Joseph E. Long ◽  
...  

CHEST Journal ◽  
2017 ◽  
Vol 152 (4) ◽  
pp. A1097
Author(s):  
Nuri Duzgun ◽  
Hidir Esme ◽  
Ibrahim Kilinc ◽  
Mustafa Calik ◽  
Mehmet Sinan Iyisoy

Sign in / Sign up

Export Citation Format

Share Document